基本信息
浏览量:0
职业迁徙
个人简介
I designed and led a single institution phase 3 randomized clinical trial, initiated in 1989, which was one of the first in the world to demonstrate that radiotherapy and concurrent chemotherapy (CRT) was more efficacious than radiotherapy alone (RT) for treating locally advanced head and neck cancer. CRT has since been established as the non-surgical standard of care for locally advanced head and neck cancer. Reduction of treatment-induced toxicity has also been a major interest of mine because more intensive therapeutic regimens improve efficacy but also increase morbidity. I was the principal investigator of the pivotal multinational randomized trial of amifostine in head and neck cancer, which established proof of principle for pharmacologic radioprotection and led to FDA approval of this drug for protection against radiation induced xerostomia in the treatment of head and neck cancer in 1999.
研究兴趣
论文共 217 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rachel F. Shenker,Niema B. Razavian, Ralph B. D'Agostino Jr,Yvonne M. Mowery,David M. Brizel,Ryan T. Hughes
ORAL ONCOLOGY (2024): 106644-106644
Oral oncology (2023): 106362-106362
David J. Carpenter,Pranalee Patel,Donna Niedzwiecki, Mairead Dillon, Alexander K. Diaz, Abhishek Kumar,Yvonne M. Mowery, Kerri-Anne Crowell, Rachel D'Anna, Qiuwen Wu, Anna Rodrigues,Amy J. Wisdom,
Journal of the National Comprehensive Cancer Networkno. 3 (2022): 224-234
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn